|
|
Сonditions and diseases
AIDS/HIV ALS Alzheimer's Disease Anemia Anti-Aging Treatment Arterial Hypertension Cancer Diabetes Treatment Eye Diseases Idiopathic Encephalopathy Ischemic Heart Disease Liver Diseases MD Treatment Multiple Sclerosis Treatment Parkinson Treatment Rheumatoid Arthritis SMA Ulcerative Colitis. Crohn’s DiseaseFeedback of the patient suffering from moderate type 2 diabetes mellitus
Patient Z., 57 years old, was accepted to the EmCell clinic with the diagnosis: type 2 moderate subcompensated diabetes mellitus. Diabetic peripheral polyneuropathy.
Patient Z. has been suffering from diabetes mellitus since 14. In April 2009, he underwent the stem cell treatment at the EmCell clinic. Two months after the cell therapy the patient reported significant decrease in his blood sugar levels, from 400-500 mg% to 190-250 mg%. He also reported insulin dose reduction, from 34 Units to 24 Units in the morning and from 24 Units to 14 Units in the evening, in total 20 Units less per day. Moreover, the patient reported eyesight improvement, reduction of neuropathy manifestations and appearance of movements in his toes. According to the patient, both he and his local doctors have been amazed with the results of the stem cell treatment and are expecting further improvements.
Patient Z. has been suffering from diabetes mellitus since 14. In April 2009, he underwent the stem cell treatment at the EmCell clinic. Two months after the cell therapy the patient reported significant decrease in his blood sugar levels, from 400-500 mg% to 190-250 mg%. He also reported insulin dose reduction, from 34 Units to 24 Units in the morning and from 24 Units to 14 Units in the evening, in total 20 Units less per day. Moreover, the patient reported eyesight improvement, reduction of neuropathy manifestations and appearance of movements in his toes. According to the patient, both he and his local doctors have been amazed with the results of the stem cell treatment and are expecting further improvements.